PENTIMALLI, FRANCESCA
 Distribuzione geografica
Continente #
NA - Nord America 421
EU - Europa 304
AS - Asia 26
Totale 751
Nazione #
US - Stati Uniti d'America 421
GB - Regno Unito 116
IE - Irlanda 80
SE - Svezia 26
UA - Ucraina 25
CN - Cina 20
DE - Germania 18
IT - Italia 12
FR - Francia 10
BE - Belgio 8
FI - Finlandia 4
RU - Federazione Russa 4
IN - India 3
ES - Italia 1
SG - Singapore 1
UZ - Uzbekistan 1
VN - Vietnam 1
Totale 751
Città #
Southend 108
Dublin 80
Fairfield 67
Ann Arbor 56
Woodbridge 38
Chandler 32
Cambridge 28
Seattle 25
Houston 23
Wilmington 23
Ashburn 22
Jacksonville 21
Menlo Park 18
New York 10
Brussels 8
Princeton 7
Boardman 4
Fort Worth 4
San Diego 4
Beijing 3
Delhi 3
Hebei 3
Shanghai 3
Venezia 3
Helsinki 2
Jiaxing 2
Moscow 2
Nanchang 2
Nanjing 2
Rome 2
San Mateo 2
Siena 2
Böblingen 1
Changsha 1
Düsseldorf 1
Hangzhou 1
Kunming 1
Málaga 1
Pozza 1
Redwood City 1
Shenyang 1
Tashkent 1
Tianjin 1
Totale 620
Nome #
NONO ubiquitination is mediated by FBW7 and GSK3 β via a degron lost upon chromosomal rearrangement in cancer 198
Pharmacological targeting of p53 through RITA is an effective antitumoral strategy for malignant pleural mesothelioma 184
Antitumoral potential, antioxidant activity and carotenoid content of two Southern Italy tomato cultivars extracts: San Marzano and Corbarino 182
Antitumor activity of new pyrazolo[3,4-d]pyrimidine SRC kinase inhibitors in Burkitt lymphoma cell lines and its enhancement by WEE1 inhibition 126
RBL2/p130 is a direct AKT target and is required to induce apoptosis upon AKT inhibition in lung cancer and mesothelioma cell lines 42
CONFIRM trial: what is the real efficacy of second-line immunotherapy in mesothelioma? 32
Totale 764
Categoria #
all - tutte 2.190
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.190


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020151 0 9 13 24 16 14 14 21 16 8 4 12
2020/2021110 3 12 4 10 5 12 4 21 11 15 7 6
2021/202270 4 13 3 2 8 0 9 3 6 6 6 10
2022/2023132 7 10 17 15 12 41 6 8 11 1 4 0
2023/202481 3 1 3 4 1 29 36 0 0 0 0 4
2024/20254 4 0 0 0 0 0 0 0 0 0 0 0
Totale 764